JP2013540712A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013540712A5 JP2013540712A5 JP2013526451A JP2013526451A JP2013540712A5 JP 2013540712 A5 JP2013540712 A5 JP 2013540712A5 JP 2013526451 A JP2013526451 A JP 2013526451A JP 2013526451 A JP2013526451 A JP 2013526451A JP 2013540712 A5 JP2013540712 A5 JP 2013540712A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- compound according
- optionally substituted
- ring
- pyrazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNPCT/CN2010/076557 | 2010-09-02 | ||
CN2010076557 | 2010-09-02 | ||
CN2011000511 | 2011-03-28 | ||
CNPCT/CN2011/000511 | 2011-03-28 | ||
CNPCT/CN2011/001227 | 2011-07-26 | ||
CN2011001227 | 2011-07-26 | ||
PCT/EP2011/064943 WO2012028629A1 (en) | 2010-09-02 | 2011-08-31 | 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2013540712A JP2013540712A (ja) | 2013-11-07 |
JP2013540712A5 true JP2013540712A5 (US07585860-20090908-C00112.png) | 2014-10-02 |
JP5781611B2 JP5781611B2 (ja) | 2015-09-24 |
Family
ID=44651698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013526451A Expired - Fee Related JP5781611B2 (ja) | 2010-09-02 | 2011-08-31 | Lrrk2キナーゼ阻害剤としての2−(ベンジルオキシ)ベンズアミド類 |
Country Status (7)
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP3902A (en) | 2012-06-29 | 2016-11-17 | Pfizer | Novel 4-(substituted-amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors |
CA2914132A1 (en) | 2013-06-21 | 2014-12-24 | Lupin Limited | Substituted heterocyclic compounds as crac modulators |
AU2014300629A1 (en) | 2013-06-24 | 2015-12-24 | Lupin Limited | Chromane and chromene derivatives and their use as CRAC modulators |
EP3083618B1 (en) | 2013-12-17 | 2018-02-21 | Pfizer Inc | Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors |
WO2016007540A2 (en) | 2014-07-10 | 2016-01-14 | The J. David Gladstone Institutes | Compositions and methods for treating dengue virus infection |
US10183938B2 (en) | 2014-12-16 | 2019-01-22 | Axovant Sciences Gmbh | Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptors |
US10875844B2 (en) | 2015-03-04 | 2020-12-29 | Dana-Farber Cancer Institute, Inc. | Salicylate inhibitors of MELK and methods of use |
MX2017016231A (es) | 2015-06-10 | 2018-11-29 | Axovant Sciences Gmbh | Compuestos de aminobencisoxazol como agonistas de receptores a7-nicotínicos de acetilcolina. |
US10428062B2 (en) | 2015-08-12 | 2019-10-01 | Axovant Sciences Gmbh | Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors |
WO2017046675A1 (en) | 2015-09-14 | 2017-03-23 | Pfizer Inc. | Novel imidazo [4,5-c] quinoline and imidazo [4,5-c][1,5] naphthyridine derivatives as lrrk2 inhibitors |
EP3592740B1 (en) | 2017-03-10 | 2022-02-09 | Pfizer Inc. | Cyclic substituted imidazo[4,5-c]quinoline derivatives |
BR112019018688A2 (pt) | 2017-03-10 | 2020-04-07 | Pfizer | derivados de imidazo[4,5-c] quinolina como inibidores de lrrk2 |
WO2023076404A1 (en) | 2021-10-27 | 2023-05-04 | Aria Pharmaceuticals, Inc. | Methods for treating systemic lupus erythematosus |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5236931A (en) * | 1992-03-26 | 1993-08-17 | A. H. Robins Company, Incorporated | 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol |
CA2413330A1 (en) | 2000-06-28 | 2002-01-03 | Smithkline Beecham P.L.C. | Wet milling process |
CA2584489C (en) | 2004-10-21 | 2014-07-22 | Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh | Kaspp (lrrke) gene, its production and use for the detection and treatment of neurodegenerative disorders |
NO323175B1 (no) | 2004-12-23 | 2007-01-15 | Jan O Aasly | Framgangsmate for a pavise en mutasjon som forarsaker arvelig parkinsonisme |
CA2657980A1 (en) | 2006-06-20 | 2007-12-27 | Novartis Ag | Biomarkers for the progression of alzheimer's disease |
WO2009127642A2 (en) * | 2008-04-15 | 2009-10-22 | Cellzome Limited | Use of lrrk2 inhibitors for neurodegenerative diseases |
CA2775753A1 (en) * | 2009-09-29 | 2011-04-07 | Paula Louise Nichols | Lrrk2 kinase inhibitors |
-
2011
- 2011-08-31 JP JP2013526451A patent/JP5781611B2/ja not_active Expired - Fee Related
- 2011-08-31 US US13/820,184 patent/US9365551B2/en active Active
- 2011-08-31 TW TW100131191A patent/TW201305109A/zh unknown
- 2011-08-31 EP EP11757574.6A patent/EP2611772B1/en not_active Not-in-force
- 2011-08-31 WO PCT/EP2011/064943 patent/WO2012028629A1/en active Application Filing
- 2011-08-31 AR ARP110103183A patent/AR082827A1/es not_active Application Discontinuation
- 2011-08-31 ES ES11757574.6T patent/ES2524892T3/es active Active